100 related articles for article (PubMed ID: 1366274)
21. Prolymphocytic leukemia or prolymphocytic transformation of mantle cell lymphoma.
Veillon DM; Nordberg ML; Glass J; Sattar T; Cotelingam JD
Am J Clin Pathol; 2001 Nov; 116(5):781-2. PubMed ID: 11710698
[No Abstract] [Full Text] [Related]
22. Leukemic pleural effusion in B-cell prolymphocytic leukemia.
Andrieu V; Encaoua R; Carbon C; Couvelard A; Grange MJ
Hematol Cell Ther; 1998 Dec; 40(6):275-8. PubMed ID: 9924927
[TBL] [Abstract][Full Text] [Related]
23. [Prolymphocytic B-cell leukemia with fatal acute liver failure. A case report].
Steidl L; Rossi A; Cornaggia M; Crippa G; Venco A
Recenti Prog Med; 1994 Mar; 85(3):186-9. PubMed ID: 8184202
[TBL] [Abstract][Full Text] [Related]
24. Sustained response of refractory prolymphocytic leukemia to fludarabine.
Sporn JR
Acta Haematol; 1991; 85(4):209-11. PubMed ID: 1853684
[TBL] [Abstract][Full Text] [Related]
25. Clinically and genetically atypical T-cell prolymphocytic leukemia underlines the relevance of a multidisciplinary diagnostic approach.
Sandberg Y; Wu KL; Heule F; van den Bos RR; Lam KH; Langerak AW; van der Velden VH; van Lom K; Beverloo HB
Haematologica; 2007 Mar; 92(3):e34-6. PubMed ID: 17405754
[No Abstract] [Full Text] [Related]
26. Prolymphocytic leukaemia.
Catovsky D
Nouv Rev Fr Hematol (1978); 1982; 24(6):343-7. PubMed ID: 6762526
[TBL] [Abstract][Full Text] [Related]
27. Possible presence of T-cell progenitors in a population of B-prolymphocytic leukemia cells.
Radnay J; Leytin V; Alter A; Ben-Tovim T; Rozenszajn LA; Klein A; Manor Y
Am J Hematol; 1994 Oct; 47(2):145-6. PubMed ID: 8092135
[No Abstract] [Full Text] [Related]
28. Allogeneic stem cell transplantation after reduced-intensity conditioning in a patient with T-cell prolymphocytic leukemia: graft-versus-tumor effect and long-term remission.
de Lavallade H; Faucher C; Fürst S; El-Cheikh J; Vey N; Coso D; Bouabdallah R; Stoppa AM; Gastaut JA; Blaise D; Mohty M
Bone Marrow Transplant; 2006 Apr; 37(7):709-10. PubMed ID: 16474410
[No Abstract] [Full Text] [Related]
29. Phase II study of cladribine and cyclophosphamide in patients with chronic lymphocytic leukemia and prolymphocytic leukemia.
Montillo M; Tedeschi A; O'Brien S; Di Raimondo F; Lerner S; Ferrajoli A; Morra E; Keating MJ
Cancer; 2003 Jan; 97(1):114-20. PubMed ID: 12491512
[TBL] [Abstract][Full Text] [Related]
30. Chlorambucil and prednisolone therapy in a patient with T-cell chronic lymphocytic leukaemia.
Islam A; Majer R; Cumber P; Poynton C
Clin Lab Haematol; 1996 Jun; 18(2):125-6. PubMed ID: 8866149
[No Abstract] [Full Text] [Related]
31. T-cell prolymphocytic leukemia: a single-institution experience.
Ravandi F; O'Brien S; Jones D; Lerner S; Faderl S; Ferrajoli A; Wierda W; Garcia-Manero G; Thomas D; Koller C; Verstovsek S; Giles F; Cortes J; Herling M; Kantarjian H; Keating M
Clin Lymphoma Myeloma; 2005 Nov; 6(3):234-9. PubMed ID: 16354329
[TBL] [Abstract][Full Text] [Related]
32. Leukemic mantle cell lymphoma with cells resembling prolymphocytes.
Onciu M; Schlette E; Bueso-Ramos C; Medeiros LJ
Am J Clin Pathol; 2002 Aug; 118(2):305-6; author reply 306. PubMed ID: 12162692
[No Abstract] [Full Text] [Related]
33. T-cell receptor gammadelta T-cell leukemia with the morphology of T-cell prolymphocytic leukemia and a postthymic immunophenotype.
Sugimoto T; Imoto S; Matsuo Y; Kojima K; Yasukawa M; Murayama T; Kohfuku J; Mizuno I; Yakushijin K; Sada A; Nishimura R; Koizumi T
Ann Hematol; 2001 Dec; 80(12):749-51. PubMed ID: 11797117
[TBL] [Abstract][Full Text] [Related]
34. [T-cell prolymphocytic leukemia].
Uchida T; Kawachi Y
Ryoikibetsu Shokogun Shirizu; 1998; (22 Pt 3):102-5. PubMed ID: 9851095
[No Abstract] [Full Text] [Related]
35. B-Prolymphocytic leukemia: a case study.
Roberts JC; Roberts GH
Clin Lab Sci; 2001; 14(4):233-7. PubMed ID: 11760820
[TBL] [Abstract][Full Text] [Related]
36. [Successful treatment by ranimustine (MCNU) of a patient with B-cell prolymphocytic leukemia (B-PLL)].
Wake A; Yamasaki Y; Ogawa R; Mori N; Nagata K; Nakata K; Misago M; Izumi Y; Fujita K; Oda S
Rinsho Ketsueki; 1993 Nov; 34(11):1464-9. PubMed ID: 8254909
[TBL] [Abstract][Full Text] [Related]
37. Are activation markers (CD25, CD38 and CD103) predictive of sensitivity to purine analogues in patients with T-cell prolymphocytic leukemia and other lymphoproliferative disorders?
Delgado J; Bustos JG; Jimenez MC; Quevedo E; Hernandez-Navarro F
Leuk Lymphoma; 2002 Dec; 43(12):2331-4. PubMed ID: 12613520
[TBL] [Abstract][Full Text] [Related]
38. Prolymphocytic transformation of a low-grade lymphocytic neoplasia: chronic lymphocytic leukemia/lymphoma [corrected].
Shahidi-Asl M; Aydin F; Beltran GS
J La State Med Soc; 1998 May; 150(5):226-31. PubMed ID: 9642926
[TBL] [Abstract][Full Text] [Related]
39. Salvage chemotherapy with pentostatin in prolymphocytic leukemia.
Pagano L; Ortu-La Barbera EO; Voso MT; Zollino M; Laurenti L; Marra R; Leone G
Haematologica; 1994; 79(6):542-5. PubMed ID: 7896214
[TBL] [Abstract][Full Text] [Related]
40. Cytogenetic studies in chronic lymphocytic leukemia, prolymphocytic leukemia and hairy cell leukemia: a progress report.
Han T; Sadamori N; Block AM; Xiao H; Henderson ES; Emrich L; Sandberg AA
Nouv Rev Fr Hematol (1978); 1988; 30(5-6):393-5. PubMed ID: 3222149
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
